Insider Transactions in Q3 2022 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2022
|
Uneek Mehra Principal Financial Officer |
SELL
Open market or private sale
|
Direct |
9,243
-4.32%
|
$166,374
$18.86 P/Share
|
|
Aug 15
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
31,214
-7.9%
|
$561,852
$18.23 P/Share
|
|
Aug 12
2022
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
124,780
+24.0%
|
-
|
|
Jul 18
2022
|
Lauren Merendino Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,704
-0.97%
|
$20,448
$12.87 P/Share
|
|
Jul 18
2022
|
David C Marek Principal Executive Officer |
SELL
Open market or private sale
|
Direct |
11,164
-2.49%
|
$133,968
$12.87 P/Share
|
|
Jul 18
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,935
-0.71%
|
$23,220
$12.87 P/Share
|
|
Jul 18
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,606
-0.63%
|
$19,272
$12.87 P/Share
|
|
Jul 06
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
3,702
-1.34%
|
$48,126
$13.4 P/Share
|
|
Jul 06
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,755
-1.06%
|
$35,815
$13.4 P/Share
|